Understanding cancer disparities in Black populations
SAMBAI - Establishing a comprehensive assessment of contributors to cancer inequities across the African diaspora
This study is looking into why Black patients, especially those from West Africa, tend to have higher rates of aggressive cancers like prostate, breast, and pancreatic cancer, and it aims to gather information from patients to help find answers that could improve cancer care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11047094 on NIH RePORTER |
What this research studies
This research investigates the reasons behind higher rates of aggressive cancers, such as prostate, breast, and pancreatic cancers, in Black patients, particularly those from West Africa. By analyzing genetic, environmental, and social factors, the study aims to uncover the underlying causes of these disparities. The research team will collaborate with scientists from the US, Africa, and the UK to create a biobank and data repository that will help in understanding the complex interactions affecting cancer outcomes. Patients may be asked to contribute biological samples and personal data to help build a comprehensive understanding of these issues.
Who could benefit from this research
Good fit: Ideal candidates for participation include Black individuals, particularly those with a family history of aggressive cancers or those living in West African regions.
Not a fit: Patients who do not identify as Black or do not have a family history of the targeted cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer prevention and treatment strategies tailored for Black populations.
How similar studies have performed: Previous research has shown success in addressing cancer disparities through genetic and environmental analyses, indicating a promising approach for this study.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Carson, Tiffany Lashaun — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Carson, Tiffany Lashaun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.